Q3 2018 Holdings
Filed 2018-11-14 | 59 holdings | $57.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Array Biopharma Inc(ARRYEUR) | Common Stocks | 04269X105 | $36.2K | 2,381,146 | 0.1% |
| Shire PLC | Common Stocks | 82481R106 | $41.4K | 228,645 | 0.1% |
| Omnicell Inc(OMCL) | Common Stocks | 68213N109 | $47.7K | 663,109 | 0.1% |
| Neogenomics Inc(NEO) | Common Stocks | 64049M209 | $56.8K | 3,700,927 | 0.1% |
| Abbvie(ABBV) | Common Stocks | 00287Y109 | $393.0K | 4,159 | 0.7% |
| Cellectis SA(CLLS) | Common Stocks | 15117K103 | $2.2M | 76,325 | 3.7% |
| Biomarin Pharmaceutical Inc(BMRN) | Common Stocks | 09061G101 | $6.0M | 62,298 | 10.5% |
| Codexis Inc(CDXS) | Common Stocks | 192005106 | $14.4M | 837,548 | 25.0% |
| Atricure Inc(ATRC) | Common Stocks | 04963C209 | $34.0M | 969,193 | 59.1% |